Viewing Study NCT03733067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-05 @ 12:11 AM
Study NCT ID: NCT03733067
Status: WITHDRAWN
Last Update Posted: 2023-12-04
First Post: 2018-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CTLA4 Haploinsufficency View
None Chronic Cytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Regulatory T Cells View
None T-cell hyperactivation View
None Autoimmune Cytopenia View
None Adult Rheumatoid Arthritis View
None Juvenile Idiopathic Arthritis View